Stock listing
LSE:0A8I Genprex, Inc. Share Price
UK listing (LSE) of Genprex, Inc. · home listing NASDAQ:GNPX
Follow Genprex, Inc. into a list and get an email when it puts out news.
Share price · LSE:0A8I
$1.92 USD +0.11 (+6.1%)
Close on Oct 27, 2026
- Day range
- $1.75 – $1.92 USDOct 27, 2026
- Volume
- 124 sharesOct 27, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GNPX · Home | $2.24 USD | +0.20 (+9.8%) | 164,563 | $2.02 | $2.27 | $2.02 | $2.04 | Close on Oct 30, 2026 |
| LSE:0A8I | $1.92 USD | +0.11 (+6.1%) | 124 | $1.89 | $1.92 | $1.75 | $1.81 | Close on Oct 27, 2026 |
- Ticker
- LSE:0A8I
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
What changed lately
Latest news release · Oct 28, 2026
Genprex to Present TUSC2 Research from Sponsored Collaboration with Meharry Medical College at the Gerontological Society of America 2026 Annual Scientific Meeting
Latest deck · Jul 14, 2026
Investor Presentation (July 2026)
Investor deck · 66 slides
Latest news
Decks
Investor Presentation (July 2026)
Investor deck · 66 slides · Jul 14, 2026
Investor Presentation (April 2026)
Investor deck · 64 slides · Apr 21, 2026
Investor Presentation (January 2026)
Investor deck · 64 slides · Jan 7, 2026
Investor Presentation (October 2025)
Investor deck · 62 slides · Oct 17, 2025
Genprex, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 126 in all · newest Oct 28, 2026 · oldest 2019
- Decks
- 26 decks · latest Jul 14, 2026
Where Genprex, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GNPX · Home listing | NASDAQ | United States | USD |
| BOATS:GNPX | BOATS | United States | USD |
| Frankfurt:2DE | Frankfurt | Germany | EUR |
| LSE:0A8I · This page | LSE | United Kingdom | USD |
| gettex:2DE | gettex | Germany | EUR |
| Munich:2DE | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Genprex, Inc.